Sycai Medical
About Sycai Medical
Sycai Medical is a Barcelona-based medtech company founded in 2020, specializing in AI and big data solutions for early cancer detection in abdominal imaging. Their core mission is to empower radiologists and transform cancer care by enhancing diagnostic accuracy, efficiency, and early detection, ultimately improving patient outcomes and quality of life.
The company develops AI-powered medical device software that assists radiologists in automatically detecting, characterizing, and monitoring lesions in the upper abdomen from routine CT scans. Their solutions, such as PANCRA™ for pancreatic cancer and LIRVEA™ for liver cancer, analyze medical imaging tests even when cancer is not the primary reason for the scan, acting as a “digital second opinion” to identify lesions that might otherwise go unnoticed. This technology is designed to integrate seamlessly into hospital PACS (Picture Archiving and Communication System) and RIS workflows, providing a “zero-clicks assistant” that retrieves and compares previous scans, offers predictive modeling for lesion progression, and generates draft reports.
Sycai Medical’s technology aims to address the challenges of late cancer diagnosis, particularly for aggressive cancers like pancreatic, liver, and kidney cancers, which are often detected at advanced stages. By identifying pre-malignant lesions and early-stage tumors, the platform helps radiologists prioritize risky cases, fast-track interventions, and monitor lesion evolution over time. The company has obtained CE mark certification under the new EU MDR for its pancreatic cancer detection application and is actively pursuing FDA approval for the US market.
Focus Areas
Business Intelligence
| Technology | AI-driven digital medical device, deep learning, big data, cloud-native, integrates with hospital PACS and RIS, DICOM compliant, zero-clicks assistant, Intel distribution of OpenVINO |
What Physicians Need to Know
Sycai Medical's AI solution acts as a 'zero-clicks assistant' that seamlessly integrates into existing radiology workflows, automatically analyzing every abdominal scan and providing a draft report. This helps radiologists by flagging abnormalities they might not be actively searching for, improving diagnostic accuracy and efficiency, and supporting earlier detection of critical cancers like pancreatic, liver, and kidney cancer. The system's ability to track lesion evolution and provide predictive modeling can aid in prioritizing patient monitoring and optimizing treatment responses.
Sycai Medical's system is designed for full integration with hospital PACS (Picture Archiving and Communication System) and RIS (Radiology Information System). It is fully DICOM compliant, allowing for automatic fetching of images and seamless workflow integration.
What the Web Says
Sycai Medical is a Barcelona-based startup founded in 2020 that specializes in AI-driven digital medical devices for the early diagnosis of abdominal cancers, including pancreatic, liver, and kidney cancers. Their technology aims to detect pre-malignant lesions from routine medical imaging, even when cancer isn't the primary focus of the scan, and automates patient monitoring. The company has received CE certification for its device and is being deployed in clinical settings in Spain and Italy, with plans for FDA approval in the United States. While there is information available about the company's mission and product, specific user reviews from platforms like G2, Glassdoor, Capterra, or Reddit for Sycai Medical are not readily available in the search results.
Overall: MixedStrengths
- AI-driven early detection of abdominal cancers (pancreatic, liver, kidney).
- Detects pre-malignant lesions from routine medical imaging.
- Automates patient monitoring.
- Aims to improve five-year survival rates for cancers like pancreatic cancer by enabling earlier detection.
- CE-certified device and deployed in clinical settings in Spain and Italy.
- Founded by experienced individuals with backgrounds in software development and AI in the medical sector.
Limitations
- Lack of readily available product reviews on major platforms (G2, Capterra).
- No specific employer reviews found on Glassdoor or Indeed.
- Limited public discussion or reviews on Reddit.
- Newer company (founded 2020), so long-term impact and widespread user feedback may still be developing.
Based on reviews from: Cancer Image Europe, How Barcelona's Sycai Medical is using AI to give cancer patients a fighting chance
Last updated: 2026-08-24
Videos
News, demos, and interviews about Sycai Medical.
Videos load interactively. If none appear, search YouTube for Sycai Medical →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Sycai Medical.
Comparisons
When considering AI tools for medical practice, physicians have distinct options like the Butterfly iQ/iQ+ Ultrasound System and Sycai Medical. The Butterfly iQ/iQ+ excels as a point-of-care ultrasound solution, offering whole-body imaging with a single handheld probe that connects to mobile devices. Its strength lies in its portability, versatility with 20+ anatomical presets, and AI-powered […]
When considering AI tools, physicians have distinct options depending on their needs. ChatGPT, particularly its Healthcare version, offers a broad, general-purpose conversational AI experience. It excels at tasks like generating human-like text, summarizing content, translating, and assisting with administrative workflows. Its key practical difference lies in its versatility and expansive application across various clinical and […]
When choosing between DeepXray and Sycai Medical, physicians should consider their primary diagnostic focus and workflow integration needs. DeepXray, developed by Alpha Intelligence Manifolds, excels in orthopedic and rheumatologic imaging, specifically for the detection and monitoring of osteoarthritis and osteoporosis. It offers automated measurements of joint space width, assessment of osteoarthritis signs, and OARSI-based grading, […]
When considering AI tools to augment radiological practice, physicians must weigh the distinct capabilities of Transpara and Sycai Medical. Transpara, developed by ScreenPoint Medical B.V., is specifically designed for breast cancer detection in both 2D and 3D mammography. Its core strengths lie in enhancing the identification of breast lesions, providing temporal comparisons with prior studies, […]
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]